EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods

Sara L White, Danielle Schoenaker iD, Sharon Mackin, Rita Forde iD, Angela C Flynn, Eleanor Dyer iD, Nicola Heslehurst iD, Robert Lindsay, Claire L Meek iD

Diabetic Medicine · 2026

DOI: 10.1111/dme.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Sara L White und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Pregnancy in Diabetics, Preconception Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, National Institute for Health and Care Research, European Foundation for the Study of Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Research to inform, co‐develop and evaluate optimal care for women with early‐onset type 2 diabetes (EOT2D) before, during and after pregnancy is lacking. Informed by patient perspectives and the results of the James Lind Alliance priority‐setting partnership in diabetes in pregnancy, we aimed to develop a consensus statement to guide future research efforts to meet the needs of women with EOT2D in the preconception, pregnancy and postnatal periods.

Methods

Results from three systematic reviews covering interventional, observational and qualitative studies were presented at the Diabetes UK annual professional conference in Glasgow in February 2025. The results were discussed by an expert panel with audience participation.

Results

There is very limited research to guide care for women with EOT2D, especially in the preconception and postnatal periods. In pregnancy, there have been limited studies assessing interventions, mainly encompassing medication and glucose sensor use, but most are small and have limited generalisability. Observational data suggests that managing glycaemia, addressing maternal BMI and preventing excessive gestational weight gain improve outcomes for women with EOT2D in pregnancy. Qualitative data highlight the negative impact of EOT2D on pregnancy and the need for optimised support. Targeted, innovative and cross‐cultural studies across the reproductive life course are urgently needed to address the short and longer‐term maternal and offspring risks for individuals with EOT2D.

Conclusions

Given the rising prevalence of EOT2D and the risk of adverse pregnancy outcomes for women with EOT2D and their children, prioritising research in the preconception, pregnancy and postnatal periods is vital to ensure that care needs are met to improve health outcomes for women and their children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Pregnancy in DiabeticsPreconception CareFemaleHumansPregnancyUnited KingdomEvidence GapsAge of Onset

Stichwörter der Autor:innen

early‐onset type 2 diabetesneonataloutcomespostnatalpreconceptionpregnancy

Autor:innen und Institutionen

  • Department of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK.
  • Department of Diabetes, Guy's and St Thomas' NHS Foundation Trust, UCL Institute for Women's Health, London, UK.
  • School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

ORCID-Profile: Danielle Schoenaker, Rita Forde, Eleanor Dyer, Nicola Heslehurst, Claire L Meek

Förderung

  • Novo Nordisk Fonden
  • National Institute for Health and Care Research
  • European Foundation for the Study of Diabetes
  • Diabetes UK

Zitieren

APA

White, S. L., Schoenaker, D., Mackin, S., Forde, R., Flynn, A. C., Dyer, E., Heslehurst, N., Lindsay, R., & Meek, C. L. (2026). A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods. Diabetic Medicine. https://doi.org/10.1111/dme.70252

Vancouver

White SL, Schoenaker D, Mackin S, Forde R, Flynn AC, Dyer E, et al. A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods. Diabetic Medicine. 2026. doi:10.1111/dme.70252

BibTeX
@article{White2026,
  author = {White, Sara L and Schoenaker, Danielle and Mackin, Sharon and Forde, Rita and Flynn, Angela C and Dyer, Eleanor and Heslehurst, Nicola and Lindsay, Robert and Meek, Claire L},
  title = {A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70252}
}
Kostenlos starten →